Physician profile
Lora Allen
NPI 1942616487
$1,759.41
in general payments reported to CMS, 2019-2025
17 companies · $977 in 2025
The $977 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $64.57 · 2023: $355 · 2024: $165 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $282.55 | 2023-2025 | Sublocade |
| Braeburn INC. | $277.77 | 2023-2025 | Brixadi |
| Abbvie INC. | $265.48 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $186.99 | 2025 | Caplyta |
| Alkermes, INC. | $146.32 | 2023-2025 | Vivitrol, Vivitrol |
| Axsome Therapeutics, INC. | $127.66 | 2025 | Auvelity, Sunosi |
| Lundbeck LLC | $86.70 | 2024-2025 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $71.57 | 2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $67.72 | 2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Amgen INC. | $53.92 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $50.27 | 2025 | Uzedy |
| Pfizer INC. | $34.68 | 2021 | |
| Ucb, INC. | $31.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.17 | 2021 | |
| Daiichi Sankyo INC. | $22.61 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.55 | 2021 | |
| Corium, LLC | $15.05 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.